AllerFund
Status
ACTIVE
Global HQ
Scarsdale, New York, United States
Countries of investment
- USA
Investment stages
- Seed
- Series A
Industries
- FoodTech
- Health Tech
- Biotechnology
- Fintech
About
AllerFund invests in food allergy solutions with a social impact focus on innovation.
AllerFund invests in food allergy solutions with a social impact focus on innovation.
Investment Thesis
AllerFund is dedicated to investing in early stage companies that focus on curing food allergies and managing allergic reactions. The firm seeks to work with scientists and entrepreneurs to develop innovative solutions in the life sciences and healthcare sectors, specifically targeting food allergies.
Manager's Experience
Specializes in growth-stage investments across technology and healthcare sectors. With deep experience in the North American and European markets, the fund manager has successfully backed over 50 startups. Known for a data-driven approach, the manager emphasizes strategic partnerships to enhance portfolio value. Recognized for achieving significant exit multiples through a combination of IPOs and strategic acquisitions. Operator-focused investment style supports sustainable scaling and innovation.